Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
R&D Expenses Over TimeContracting
Percentile Rank71
3Y CAGR+4.1%
5Y CAGR+32.4%
Year-over-Year Change
Research and development spending
3Y CAGR
+4.1%/yr
Annual compound
5Y CAGR
+32.4%/yr
Recent deceleration
Percentile
P71
Within normal range
vs 5Y Ago
4.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $41.11M | -18.6% |
| 2024 | $50.48M | +6.8% |
| 2023 | $47.25M | +29.6% |
| 2022 | $36.45M | +37.5% |
| 2021 | $26.51M | +162.8% |
| 2020 | $10.09M | +18.8% |
| 2019 | $8.49M | - |
| 2018 | $0.00 | - |